Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection
Elia Moreno-Cubero, Aljawharah Alrubayyi, Stefan Balint, Ane Ogbe, Upkar S. Gill, Rebecca Matthews, Sabine Kinloch, Fiona Burns, Sarah L. Rowland-Jones, Persephone Borrow, Anna Schurich, Michael Dustin, Dimitra Peppa
Elia Moreno-Cubero, Aljawharah Alrubayyi, Stefan Balint, Ane Ogbe, Upkar S. Gill, Rebecca Matthews, Sabine Kinloch, Fiona Burns, Sarah L. Rowland-Jones, Persephone Borrow, Anna Schurich, Michael Dustin, Dimitra Peppa
View: Text | PDF
Research Article AIDS/HIV Immunology

IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection

  • Text
  • PDF
Abstract

Dynamic regulation of cellular metabolism is important for maintaining homeostasis and can directly influence immune cell function and differentiation, including NK cell responses. Persistent HIV-1 infection leads to a state of chronic immune activation, NK cell subset redistribution, and progressive NK cell dysregulation. In this study, we examined the metabolic processes that characterize NK cell subsets in HIV-1 infection, including adaptive NK cell subpopulations expressing the activating receptor NKG2C, which expand during chronic infection. These adaptive NK cells exhibit an enhanced metabolic profile in HIV-1– individuals infected with human cytomegalovirus (HCMV). However, the bioenergetic advantage of adaptive CD57+NKG2C+ NK cells is diminished during chronic HIV-1 infection, where NK cells uniformly display reduced oxidative phosphorylation (OXPHOS). Defective OXPHOS was accompanied by increased mitochondrial depolarization, structural alterations, and increased DRP-1 levels promoting fission, suggesting that mitochondrial defects are restricting the metabolic plasticity of NK cell subsets in HIV-1 infection. The metabolic requirement for the NK cell response to receptor stimulation was alleviated upon IL-15 pretreatment, which enhanced mammalian target of rapamycin complex 1 (mTORC1) activity. IL-15 priming enhanced NK cell functionality to anti-CD16 stimulation in HIV-1 infection, representing an effective strategy for pharmacologically boosting NK cell responses.

Authors

Elia Moreno-Cubero, Aljawharah Alrubayyi, Stefan Balint, Ane Ogbe, Upkar S. Gill, Rebecca Matthews, Sabine Kinloch, Fiona Burns, Sarah L. Rowland-Jones, Persephone Borrow, Anna Schurich, Michael Dustin, Dimitra Peppa

×

Figure 4

IL-15 treatment ameliorates NK cell metabolic requirements for receptor stimulation in HIV-1 infection.

Options: View larger image (or click on image) Download as PowerPoint
IL-15 treatment ameliorates NK cell metabolic requirements for receptor ...
(A) Representative flow plots showing IFN-γ production by CD56dim NK cells from an HIV-1+ donor following stimulation with anti-CD16 with or without IL-15 pretreatment and in the presence or absence of the following inhibitors: oligomycin or 2-DG. The representative ex vivo flow panel corresponds to the same HIV-1 donor depicted in Figure 2A (bottom panel), showing paired responses to ex vivo stimulation with anti-CD16 and following IL-15 pretreatment within the same donor. (B) Paired analysis showing IFN-γ production ex vivo and following IL-15 priming in response to anti-CD16 stimulation from NK cells (n = 6). Ex vivo: 6-hour stimulation with anti-CD16; IL-15 pretreatment: incubation with IL-15 for 48–72 hours followed by 6-hour anti-CD16 stimulation. (C) Summary data showing IFN-γ production in response to isotype control or anti-CD16 stimulation, following IL-15 pretreatment, in the presence of oligomycin or 2-DG by CD56dim, canonical, and adaptive NK cells from n = 6 HIV-1+ donors. Data are shown as mean ± SD. (D and E) Representative histograms and summary bar charts of pS6 expression levels to evaluate mTORC1 activity after stimulation in CD56dim NK cells from n = 6 HIV-1+ individuals. (F) Real-time analysis of aerobic glycolysis (ECAR) and basal oxygen consumption rate (OCR) in purified NK cells from n = 3 HIV-1+ donors in the presence or absence of anti-CD16 and/or IL-15 pretreatment. (G) OCR/ECAR ratio in NK cells from HIV-1+ individuals. Significance was determined by Wilcoxon matched-pairs signed-rank test and paired t test for G. One-way ANOVA with multiple-comparison test was performed for C and E; *P < 0.05, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts